Table 1.
Clinicopathological factors of bladder cancer and associations with DYRK2 expression
| Patients (%) | DYRK2 expression | |||
|---|---|---|---|---|
| Negative | Positive | P | ||
| All patients | 44 | 23 | 21 | |
| Age | 0.35 | |||
| <70 years | 17 (39 %) | 7 | 11 | |
| ≥70 years | 27 (61 %) | 16 | 10 | |
| Sex | 0.70 | |||
| Male | 36 (82 %) | 18 | 18 | |
| Female | 8 (18 %) | 5 | 3 | |
| Pathological T stage | 0.27 | |||
| 1 | 14 (32 %) | 5 | 9 | |
| 2a | 20 (46 %) | 11 | 9 | |
| 2b | 10 (23 %) | 7 | 3 | |
| Histological grade | ||||
| Low | 3 (7 %) | 1 | 2 | 0.60 |
| High | 41 (93 %) | 22 | 19 | |
| Concurrent CIS | 0.23 | |||
| Yes | 7 (16 %) | 2 | 5 | |
| No | 37 (84 %) | 21 | 16 | |
| Lymphovascular invasion | 1.00 | |||
| Yes | 3 (7 %) | 2 | 1 | |
| No | 41 (93 %) | 21 | 20 | |